Odisha’s First Vaccine Manufacturing Plant ‘Sapigen Biologix’ To Start Production By May 2024

Bhubaneswar: Commercial production at the Sapigen Biologix vaccine plant in Odisha, the first such facility in the state, will commence by May this year, officials said on Sunday.

The plant at the Biotech Park in Andharua near here will have a capacity to produce 2.4 crore doses of different vaccines per day, they said.

At full capacity, this facility will be the biggest vaccine-producing plant in the country, the Chief Minister’s Office (CMO) said in a statement.

It is expected to produce over 15 vaccines for various diseases, including cholera and malaria.

The Rs 1,500-crore vaccine plant will create direct employment for 1,500 people, with most of them being local recruits, the CMO said.

The variety of vaccines produced in Bhubaneswar will be supplied to many parts of the world, it added.

V K Pandian, the chairman of ‘5T’ technology-led transformative initiatives on Sunday visited the sub-units and interacted with the management and employees. He urged all government agencies to assist in the commissioning of the plant within the next three months.

Related Posts

Nurse, another arrested in ASHA worker’s death at illegal hospital; main accused at large

Sonbhadra, A nurse and her assistant were arrested in connection with the death of an ASHA worker during childbirth at an illegally operated hospital in Kon area, police said on…

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

Lucknow: King George’s Medical University (KGMU) will file an FIR against four employees after a probe found alleged irregularities worth around Rs 2.5 crore in medicines procurement under the Asadhya…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nurse, another arrested in ASHA worker’s death at illegal hospital; main accused at large

Nurse, another arrested in ASHA worker’s death at illegal hospital; main accused at large

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

Haryana Launches ‘Make in Haryana Industrial Policy’

Haryana Launches ‘Make in Haryana Industrial Policy’

A new pancreatic cancer pill may be a game changer for patients

A new pancreatic cancer pill may be a game changer for patients

NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads